These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2932509

  • 1. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T, Ohgaki K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):609-17. PubMed ID: 2932509
    [No Abstract] [Full Text] [Related]

  • 2. [Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T.
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct 20; 19(9):2179-87. PubMed ID: 6530585
    [No Abstract] [Full Text] [Related]

  • 3. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
    Nio Y, Inamoto T, Hori T, Kan N, Tsuchitani T, Kodama H, Tobe T, Ohgaki K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):597-608. PubMed ID: 4056544
    [No Abstract] [Full Text] [Related]

  • 4. [Oral administration of streptococcal preparation "OK 432 (picibanil)"--the second report: experimental studies on its absorption and the responses of the gut associated lymphoid tissue].
    Nio Y, Ohgaki K, Inamoto T, Hori T, Nakayama N, Yamasaki N, Kan N, Hikasa Y, Tsuchitani T, Nagai T.
    Nihon Gan Chiryo Gakkai Shi; 1984 Feb 20; 19(1):71-9. PubMed ID: 6527068
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y, Ohgaki K, Henmi K, Kan N, Inamoto T, Tsuchitani T, Kodama H, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr 20; 17(3):728-34. PubMed ID: 6752308
    [No Abstract] [Full Text] [Related]

  • 6. [Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].
    Nio Y, Inamoto T, Kan N, Hori T, Nakayama N, Yamasaki N, Hikasa Y, Tsuchitani T, Ban S, Nagai T.
    Nihon Gan Chiryo Gakkai Shi; 1984 May 20; 19(4):803-10. PubMed ID: 6491430
    [No Abstract] [Full Text] [Related]

  • 7. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y, Tobe T.
    Nihon Geka Gakkai Zasshi; 1989 Sep 20; 90(9):1436-8. PubMed ID: 2586435
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y, Shiraishi T, Tsuchitani T, Tobe T, Sugawara Y, Saito M, Kamiyama H.
    In Vivo; 1989 Sep 20; 3(5):307-13. PubMed ID: 2519870
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
    Komatsu K, Nakamura W.
    C R Seances Soc Biol Fil; 1986 Sep 20; 180(1):117-20. PubMed ID: 2943364
    [Abstract] [Full Text] [Related]

  • 11. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
    Nio Y, Ohgaki K, Kan N, Tsuchitani T, Imai S, Okino T, Hori T, Tobe T, Nakamura M, Kodama H.
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec 20; 22(10):2436-45. PubMed ID: 3449590
    [No Abstract] [Full Text] [Related]

  • 12. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
    Baba H, Tsujitani S, Korenaga D, Kakeji Y, Haraguchi M, Konoe S, Maehara Y, Sugimachi K.
    Gan To Kagaku Ryoho; 1990 Aug 20; 17(8 Pt 2):1596-9. PubMed ID: 2389954
    [Abstract] [Full Text] [Related]

  • 13. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
    Kan N, Hori T, Ohgaki K, Inamoto T, Kodama H, Tobe T.
    Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 2):1298-306. PubMed ID: 3488027
    [Abstract] [Full Text] [Related]

  • 14. Effect of streptococcal preparation, OK-432, on experimental infection due to Mycobacterium lepraemurium in mice of C3H/Jms strain.
    Saito H, Tomioka H, Sato K.
    Hiroshima J Med Sci; 1983 Jun 20; 32(2):231-4. PubMed ID: 6352569
    [No Abstract] [Full Text] [Related]

  • 15. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.
    Takeshita M, Makita F, Takeyoshi I, Ishikawa H, Nakamura S, Owada S, Miyamoto Y, Izuo M, Kurashige S.
    Jpn J Surg; 1990 May 20; 20(3):316-26. PubMed ID: 2359208
    [Abstract] [Full Text] [Related]

  • 16. Effect of a streptococcal preparation, OK-432, on hematopoietic spleen colony formation in irradiated mice.
    Hiraoka A, Yamagishi M, Ohkubo T, Kamamoto T, Yoshida Y, Uchino H.
    Cancer Res; 1981 Jul 20; 41(7):2954-8. PubMed ID: 7018674
    [Abstract] [Full Text] [Related]

  • 17. [Combined effect of intraperitoneally administered OK-432 and recombinant interleukin (rIL-2) against mouse tumors].
    Fujioka T, Shiraishi M, Tanji S, Koike H, Kumagai K, Kubo T, Ohhori T.
    Nihon Gan Chiryo Gakkai Shi; 1989 May 20; 24(5):948-56. PubMed ID: 2789265
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
    Hosoi J, Wakasugi H, Miyata M, Minato N, Imai M.
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):2044-55. PubMed ID: 7169577
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug 20; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 20. [Inhibition of pulmonary metastasis in mice by OK-432--MCT emulsion administrated enterally].
    Masuyama K, Tazawa K, Kasagi T, Yamashita I, Ishizawa S, Fujimaki M, Ochiai H, Niwayama S, Matsui H.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun 20; 23(6):1300-6. PubMed ID: 3230345
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.